Study looks at differences in celiac disease treatments

10/5/2011 |

Practicing gastroenterologists and academic experts treat celiac disease differently, according to a study in the Journal of Clinical Gastroenterology. The study found they differ in their use of IgA anti-endomysial antibodies, human leukocyte antigen DQ2/8 testing, gluten challenge and oat consumption, and academics were more likely to recommend celiac testing for Type 1 diabetics, people with Down and Turner syndromes and relatives of people with celiac disease.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Director, Corporate Counsel
Tarrytown, NY